TOP1 and small cell lung carcinoma: Topotecan (Tpc) is a topoisomerase 1 (TOP1) inhibitor from the camptothecin group and can be used in clinical practice for the treatment of cervical, ovarian cancer [4], colon cancer, and small cell lung cancer [5].